King v. Douglass

973 F. Supp. 707, 1996 U.S. Dist. LEXIS 21665, 1996 WL 907734
CourtDistrict Court, S.D. Texas
DecidedDecember 23, 1996
DocketCivil Action H-96-1033
StatusPublished
Cited by14 cases

This text of 973 F. Supp. 707 (King v. Douglass) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
King v. Douglass, 973 F. Supp. 707, 1996 U.S. Dist. LEXIS 21665, 1996 WL 907734 (S.D. Tex. 1996).

Opinion

ORDER

HARMON, District Judge.

Pending before the Court in the above referenced class action and derivative complaint, brought pursuant to Sections 36(a) and 36(b) of the Investment Company Act of 1940 (“ICA”), 15 U.S.C. § 80a-35(a) and (b) (1976) and alleging violations of the ICA and common-law breach of fiduciary duties to a closed-end fund’s shareholders and ultra vires acts, illegally conducted without the required approval vote of a majority of the shares, are the following motions: Plaintiffs Kevin King and David L. Massarano’s motion for class certification pursuant to Rule 23(b)(3) (instrument # 19); Defendants Sam P. Douglass, Nolan Lehmann, Gregory Flanagan, Robert L. Knauss, John W. Storms, Francis D. Tuggle, Edward E. Williams, Gary R. Peterson, 1 Equus Capital Management Corporation (“ECM” or “the Adviser”), and Equus II, Inc.’s (“the Fund’s”) 2 amended motion to dismiss (# 26); and Defendants’ motion to partially stay discovery (#28). Plaintiffs seek declaratory relief and damages.

Plaintiffs’ complaint, at 10, explains that unlike open-end funds, which can repeatedly hold public offerings of new shares, closed-end funds do not usually issue new shares after the initial offering and therefore do not *710 expand through infusions of new, outside capital. Instead, closed-end funds usually expand only through the gradual increase in the value of their underlying portfolio. Plaintiffs allege that Equus II, Inc. (“the Fund”), here, has been hurt by the steep discount of the market price of its stock in relation to its NAV, approximately 30%, in the past three years.

Kevin King currently owns 10,000 shares of the Fund, while David Massarano owns 1,199 shares. Plaintiffs sue on behalf of themselves and a proposed class of all persons who owned shares of the Fund as of March 5, 1996 other than named Defendants here. On that date, the complaint alleges, in breach of their fiduciary duties, the Fund’s directors, the Fund, and the Fund’s investment adviser, all Defendants here, announced that the Fund would conduct a rights offering and issue up to 1,046,191 new shares of stock, thereby increasing the number of outstanding shares by up to 33% if fully subscribed. 3 Pointing to authority in the investment field, Plaintiffs assert that in most cases, since closed-end funds cannot sell shares whenever they need more cash, such rights offerings to shareholders are not for the benefit of the shareholders because they constitute a way to extort more money from existing shareholders who feel compelled to pay for initial shares to avoid having the value of their holdings diluted. Plaintiffs contend that the Securities and Exchange Commission (“SEC”), in interpreting and applying the ICA, has indicated that a closed-end fund’s directors and investment adviser have a heavy burden to demonstrate that a proposed rights offering’s “expected” benefits “clearly outweigh” any injury to participating and nonpartieipating shareholders. Plaintiffs contend that the March 1996 rights offering will injure both participating and nonparticipating shareholders by diluting both the net asset value (“NAV”) and the market value of their investment in the Fund. Plaintiffs also bring this action pursuant to Section 36(b) 4 of the ICA derivatively, on behalf of the Fund, against its investment adviser, ECM, for breach of fiduciary duty regarding the Fund’s compensation.

More specifically, the complaint explains that on December 31, 1995, the Fund’s shares traded at a 30% discount to the NAV of the stocks owned, and that at the end of February 1996, the Lipper Analytic Survey ranked the Fund’s 26.6% discount as the largest of those it surveyed. 5

Plaintiffs argue that by pricing the 1996 transferable rights offering’s new shares at a *711 steep discount to current market prices, the offering imposes a downward pressure on the trading price for the Fund’s shares and threatens dilution of existing shareholders’ interests. 6 Moreover because of the “coercive” structure of the rights offering, Plaintiffs claim that existing shareholders are faced with three unsatisfactory choices: purchasing additional shares of newly issued stock at a steep discount to the Fund’s NAV, suffer dilution of their pro rata ownership interest in the Fund and monetary damage to their existing investment, or sell their shares in a depressed market and suffer market damages.

Under the ICA and under Delaware common law, allege Plaintiffs, the Director Defendants and Adviser ECM have fiduciary duties to the Fund’s shareholders to act fairly, equitably and with due care in promoting and protecting the interests of the Fund’s shareholders. Therefore, when faced with a proposed discounted rights offering, since section 23(b) of the ICA 7 generally prohibits a registered, closed-end investment company from selling to the public its shares at a price below the NAV with certain exceptions, because transferable rights offerings below the NAV involve dilution of existing shareholders’ assets, earnings, and relative voting power the fiduciary directors and adviser bear a heavy burden to demonstrate the “expected” benefits of the offering “clearly outweigh” 8 injuries to the shareholders of the Fund. Before approving such an offering, the fidu *712 ciaries must demonstrate that the benefits created by the offering (1) are “expected” benefits, not just possible, speculative, or hoped for benefits, (2) -will accrue to all shareholders, whether they exercise their rights or not, and (3) are larger than the harm caused by the approved offering.

Plaintiffs maintain that the transferable rights 9 offering by Defendants will depress the market trading values of the Fund’s shares for all shareholders and dilute the value of shareholder investment in the Fund, especially for shareholders who do not exercise their rights. Nor, argue Plaintiffs, are the dilutive effects offset by the “speculative” benefits claimed by Defendants, i.e., providing the Fund with capital to pay down debt and reduce the Fund’s expense ratio and providing existing shareholders with an opportunity to purchase additional shares of common stock at a price that may be below market value of NAV without the transaction costs that would be associated with open-market purchases. Furthermore, the amount of the management fees paid to ECM will increase with the increase in total assets.

Plaintiffs insist that under Section 23(b) of the ICA, 15 U.S.C. § 80a-23(b), closed-end funds are prohibited from conducting the kind of discounted offering at issue here:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Enron Corp. Securities, Derivative & Erisa Lit.
761 F. Supp. 2d 504 (S.D. Texas, 2011)
Forsythe v. Sun Life Financial, Inc.
475 F. Supp. 2d 122 (D. Massachusetts, 2007)
Stegall v. Ladner
394 F. Supp. 2d 358 (D. Massachusetts, 2005)
Strougo v. Bassini
282 F.3d 162 (Second Circuit, 2002)
Strougo v. Bassini
112 F. Supp. 2d 355 (S.D. New York, 2000)
Krantz v. Fidelity Management & Research, Co.
98 F. Supp. 2d 150 (D. Massachusetts, 2000)
Maxxim Medical, Inc. v. Michelson
51 F. Supp. 2d 773 (S.D. Texas, 1999)
Strougo Ex Rel. the Brazil Fund, Inc. v. Padegs
27 F. Supp. 2d 442 (S.D. New York, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
973 F. Supp. 707, 1996 U.S. Dist. LEXIS 21665, 1996 WL 907734, Counsel Stack Legal Research, https://law.counselstack.com/opinion/king-v-douglass-txsd-1996.